New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 23, 2012
10:32 EDTLGF, RY, BMC, XOM, HTWR, AZN, COF, STD, ARMHOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: ARM Holdings (ARMH) upgraded to Neutral from Underweight at JPMorgan... AstraZeneca (AZN) upgraded to Equal Weight from Underweight at Barclays... BMC Software (BMC) upgraded to Positive from Neutral at Susquehanna... Banco Santander (STD) upgraded to Conviction Buy from Neutral at Goldman... Banco Santander upgraded to Overweight from Neutral at JPMorgan... HeartWare (HTWR) upgraded to Overweight from Equal Weight at Barclays... Royal Bank of Canada (RY) upgraded to Buy from Neutral at BofA/Merrill... Capital One (COF) upgraded to Overweight from Neutral at JPMorgan... Exxon Mobil (XOM) upgraded to Outperform from Market Perform at Raymond James... Lions Gate (LGF) upgraded to Above Average from Average at Caris.
News For ARMH;AZN;BMC;STD;HTWR;RY;COF;XOM;LGF From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 8, 2015
09:44 EDTLGFLionsgate trades lower following secondary, levels to watch
Subscribe for More Information
09:20 EDTLGFOn The Fly: Pre-market Movers
Subscribe for More Information
09:01 EDTLGFLionsgate 10M share Spot Secondary priced at $32.00
JPMorgan acted as sole book running manager for the offering.
06:30 EDTCOFCapital One remains top card issuer pick at Citigroup
In its preview of Q1 results, Citigroup says Capital One (COF) remains its top pick among the card issuers given the company's "strong" card loan growth, capital return and "reasonable" valuation. Citi keeps a Buy rating on the stock with a $95 price target. The firm continues to see a "modestly" improving U.S. consumer, and also has Buy ratings on American Express (AXP), Discover (DFS), MasterCard (MA), Synchrony Financial (SYF) and Visa (V). Citi thinks investor sentiment has become more negative for card issuers around provisioning for loan growth with the group posting mixed stock performance thus far in 2015.
06:21 EDTLGFLionsgate 10M share Spot Secondary; price range $32.01-$33.00
The Lionsgate 10M shares Spot Secondary is being re-offered in the range of $32.01-$33.00 versus a $33.68 close. JPMorgan is acting as sole book running manager for the offering.
06:06 EDTAZNInovio selected by DARPA to lead $45M Ebola prevention program
Subscribe for More Information
06:02 EDTLGFLionsgate should be bought on any weakness, says Piper Jaffray
Subscribe for More Information
April 7, 2015
19:10 EDTLGFOn The Fly: After Hours Movers
Subscribe for More Information
16:19 EDTLGFLionsgate says tracking at lower end of previous adjusted EBITDA guidance
Subscribe for More Information
16:12 EDTAZNRegulus up 5% after RG-125 selected as clinical candidate by AstraZeneca
Subscribe for More Information
16:12 EDTAZNRegulus RG-125 selected as clinical candidate by AstraZeneca
Regulus Therapeutics (RGLS) announced the selection of RG-12, a GalNAc-conjugated anti-miR targeting microRNA-103/107, or miR-103/107, for the treatment of Non Alcoholic Steatohepatitis, or NASH, in patients with type 2 diabetes/pre-diabetes, as a clinical candidate by AstraZeneca (AZN) under the companies' strategic alliance to discover, develop and commercialize microRNA therapeutics. RG-125 is the first compound from the alliance to be selected for clinical development by AstraZeneca. In connection with the candidate selection, AstraZeneca will pay Regulus $2.5M and will assume development of the program following acceptance of an Investigational New Drug application. In the near term, Regulus and AstraZeneca plan to submit key preclinical data on the RG-125 program to be presented at a scientific meeting later this year and expect to initiate a Phase I study of RG-125 in humans by the end of 2015.
16:05 EDTLGFLionsgate files to sell 10M shares of common stock for holders
JPMorgan is acting as sole book running manager for the offering.
10:48 EDTHTWRLeerink medical supplies & devices analyst has analyst/industry conference call
Subscribe for More Information
07:14 EDTAZNEyeforpharma to hold a summit
Philadelphia 2015 Commercial Pharma Summit is being held in Philadelphia on April 7-8.
06:43 EDTXOMOil retreats on reports of Iran, China talks, Reuters says
Subscribe for More Information
06:40 EDTXOMExxon, NJ settlement controversy to continue, WSJ says
Subscribe for More Information
April 6, 2015
08:58 EDTHTWRCredit Suisse more optimistic on HeartWare
Subscribe for More Information
06:41 EDTXOMOil up after Saudi Arabia increases prices for Asia, Reuters says
Subscribe for More Information
April 5, 2015
18:34 EDTLGFComcast's 'Furious 7' leads at weekend box office with $143.6M
Subscribe for More Information
18:12 EDTXOMOil falls after tentative nuclear deal for Iran, Reuters says
After a preliminary pact between Iran and world powers on Tehran's nuclear program the price of Brent oil fell nearly 4% on Thursday, says Reuters. Publicly traded companies in the space include BP (BP), Chevron (CVX), ConocoPhillips (COP), Exxon Mobil (XOM), Royal Dutch Shell (RDS.A) and Total (TOT). Reference Link
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use